Your selection

Research, Innovation, Patient care, Education / 18.09.2025
Talk in the Cube: IP STRATEGIES IN BIOTECHNOLOGY

Talk in the Cube in September 2025
Talk in the Cube in September 2025

We are excited to continue the Talks in the Cube with an expert discussion focused on Strategies for Intellectual Property Rights in Biotechnology.

Effective strategies for Intellectual Property (IP) in Biotechnology include using patents for new processes and products, applying trade secrets for complex bioengineering methods, and employing trademarks for branding. A comprehensive strategy also means building adequate patent portfolios through patent jungles or "Biobetters", monitoring and defending IP rights against infringement, and potentially using licensing agreements for technology transfer.
Our two esteemed experts who are trained natural scientists AND European Patent Attorneys. They will share their insights and experiences with us.

A Panel Discussion with

Dr. Sun Jin Lee, European Patent Attorney, European Patent Litigator (UPC), Maiwald GmbH, Munich  
Dr. Oliver Ladendorf, LL.B., European Patent Attorney, Kraus & Lederer PartGmbH, Munich

Dr. Uwe Lohmeier, Berlin BioScience Academy (BBA), Campus Berlin Buch GmbH (Moderation).

Topics planned to be addressed

  • Smart patenting for Biotech: Portfolios providing leverage and attracting  investors
  • Licensing of innovative technologies: Patents for organoids and CRISPR/Cas
  • Biotech Patents and AI: Examples to influence innovations and to protect data-driven discoveries.

The talk will be followed by a networking event where you can socialize over snacks and drinks.

Target audience 
Founders & scientists from start-ups, small and medium-sized life science companies and scientific institutions. 

Costs 
Participation is free of charge. Registration is requested. 

When 
Thursday, 18 September 2025 
5:00 p.m. - 7:00 p.m.

Where
BerlinBioCube (Building D95), Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin

Quelle: BerlinBioscience Academy
Further information and registration

Overview News

News Buch Berlin

A Leap into the World of Big Pharma

The Successful Transformation of a Startup: An Interview with Dr. Christian Regenbrecht, Vice President of Translational Oncology at GSK and Founder of CELLphenomics

more ...

Alithea Bio Scores Double Victory at VivaTech 2026 for Breakthrough in Preclinical Safety

Deep-tech biotech innovator Alithea Bio has achieved a spectacular double victory at VivaTech 2026, Europe’s largest startup and tech event, taking home both the coveted “Tech for Change” Jury Prize a...

more ...

Eckert & Ziegler SE Annual General Meeting Approves Significantly Higher Dividend

The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board and resolved to pay a dividend of € 0.22 per share (previ...

more ...

Events Buch Berlin

27.08.2026, 10:00
CRISPR/Cas: Grundlagen und praktische Anwendung (Verschoben vom 4. Juni auf 27. August)

Der Crashkurs für Einsteiger*innen vermittelt die Grundlagen der CRISPR/Cas Technologie. Die Teilnehmer*innen sollen in die Lage versetzt werden, CRISPR/Cas Experimente selbständig zu planen und durch...

more ...

22.09.2026, 09:00
GMP Biotech Summer School

Knowing and applying the Good Manufacturing Practice (GMP) regulations is one of the key elements in the manufacture of medicinal products for clinical trials and on an industrial level.

more ...

09.11.2026, 09:00
Fachkraft für Molekularbiologie

Elftägiges Intensivseminar der Berlin BioScience Academy. Es rmittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschu...

more ...

This website is supported by: